The company in question is, CR Bard Inc. (NYSE:BCR) currently with a stock price of 221.89 (-4.14% today). The market cap for CR Bard Inc. is 17077.86, and is in the sector Healthcare, and Medical Instruments & Supplies industry. The target price for CR Bard Inc. is 232.62. Currently CR Bard Inc. is trading with a P/E of 102.51, and a forward P/E of 20.6. Average volume for CR Bard Inc. is 474.93 and so far today it is 563677.
Performance in the last year for CR Bard Inc. has been 22.33%. For EPS growth, CR Bard Inc. has seen a growth of -52.90%, and is looking to grow in the next year to 10.74%. More long term stats show that EPS growth has been -19.80% over the last five years and could be 10.80% for the next five years. CR Bard Inc. has seen sales growth quarter over quarter at 6.60%, with EPS growth quarter over quarter at -16.70%. The 20-day simple moving average is -2.30%, with the 200-day simple moving average coming to 10.52%.
Since the IPO date for CR Bard Inc. on the 4/6/1983, CR Bard Inc. has seen performance year to date to be 22.63%. With CR Bard Inc. trading at 221.89, the dividend yield is 0.45%, and the EPS is 2.26.
So could CR Bard Inc., be undervalued? Well as said before P/E is 102.51. The PEG is 9.49, P/S is 4.92 and the P/B is at 11.73. The P/cash is 22.32, with P/free cash flow at *TBA.
CR Bard Inc. ability to deal with debt shows that the current ratio is 1.5, and the quick ratio is 1.2. This is with long term debt/equity at 0.78, and total debt/equity at 1.14.
In terms of margins, CR Bard Inc. has a gross margin of 62.20%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for CR Bard Inc. is *TBA. Return on assets come to *TBA with return on investment coming to 6.40%.
Insider ownership for CR Bard Inc., is at 0.50% and institutional ownership comes to 91.10%. Outstanding shares are at 73.78. While shares float is 73.18. The float short is currently 1.70%, and short ratio is 2.62.